pyrroles has been researched along with Allergic Encephalomyelitis in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 10 (47.62) | 29.6817 |
2010's | 10 (47.62) | 24.3611 |
2020's | 1 (4.76) | 2.80 |
Authors | Studies |
---|---|
Jiang, S | 1 |
Abtahi Froushani, SM; Delirezh, N; Hobbenaghi, R; Mosayebi, G | 1 |
Dunn, SE; Prod'homme, T; Steinman, L; Weber, MS; Youssef, S; Zamvil, SS | 1 |
Cvetanovic, M; Lin, W; Lin, Y; Pang, X; Stanojlovic, M; Stone, S | 1 |
Balbo, P; Banker, ME; Bauman, J; Brown, MF; Casimiro-Garcia, A; Clark, JD; Crouse, K; Dickinson, C; Dowty, ME; Geoghegan, KF; Gilbert, AM; Hayward, M; Hegen, M; Hett, E; Jones, L; Jussif, J; Leung, L; Li, L; Li, W; Liang, S; Lin, T; Montgomery, J; Moy, E; Quazi, A; Symanowicz, P; Telliez, JB; Thorarensen, A; Trujillo, JI; Unwalla, R; Vajdos, FF; Vincent, F; Wang, L; Wright, K; Xuan, D; Yang, X; Zhao, Y | 1 |
Guo, H; Leng, X; Liu, Y; Luo, S; Luo, X; Mo, C; Su, Z; Wang, Y; Zhou, Y; Zou, Q | 1 |
Chevot, F; Connon, SJ; Cotter, M; Cunningham, C; Fergus, C; Kelly, VP; Mills, KH; Southern, JM; Varghese, S | 1 |
Hashimoto, K; Higashi, T; Matsushita, S; Nakano, K; Takagi, R; Tanaka, Y | 1 |
Carter, DE; Karlik, SJ; Roscoe, WA; Welsh, ME | 1 |
Ansorge, S; Bank, U; Biton, A; Brocke, S; Reinhold, D; Täger, M | 1 |
Fukaya, T; Inoue, H; Kimura, A; Morita, R; Sekiya, T; Shichita, T; Yoshida, H; Yoshimura, A | 1 |
Contino-Pepin, C; Karlik, SJ; Patinote, C; Roscoe, WA | 1 |
Chen, L; Guo, L; Li, R; Li, Z; Liu, J; Niu, X; Ping, M; Xie, X | 1 |
Wekerle, H | 1 |
Bravo, M; Hur, EM; Mitchell, DJ; Patarroyo, JC; Radosevich, JL; Ruiz, PJ; Sobel, RA; Steinman, L; Stüve, O; Youssef, S; Zamvil, SS | 1 |
Aktas, O; Brocke, S; Dorr, J; Endres, M; Nitsch, R; Prozorovski, T; Sallach, S; Seeger, B; Smorodchenko, A; Waiczies, S; Zipp, F | 1 |
Koh, CS | 1 |
Dunn, SE; Goldstein, MJ; Prod'homme, T; Steinman, L; Weber, MS; Youssef, S; Zamvil, SS | 1 |
Hemmer, B; Nessler, S; Prod'homme, T; Sobel, RA; Steinman, L; Stüve, O; von Büdingen, HC; Weber, MS; Youssef, S; Zamvil, SS | 1 |
Antipova, V; Bansemer, S; Böttcher, T; Dazert, E; Gierl, L; Gimsa, U; Glass, A; Hoffrogge, R; Ibrahim, SM; Karopka, T; Koczan, D; Kundt, G; Lemcke, S; Mazón-Peláez, I; Mix, E; Müller, J; Pahnke, J; Rolfs, A; Scheel, T; Strauss, U; Warzok, R; Wree, A; Zschiesche, M | 1 |
Ballerini, C; Bellucci, A; Biagioli, T; Biamonte, F; Casamenti, F; Grossi, C; Luccarini, I; Massacesi, L; Rosi, MC | 1 |
3 review(s) available for pyrroles and Allergic Encephalomyelitis
Article | Year |
---|---|
Tetrameric PKM2 Activation Curbs CD4
Topics: Animals; CD4-Positive T-Lymphocytes; Encephalomyelitis, Autoimmune, Experimental; Humans; Pyridazines; Pyrroles; Pyruvate Kinase; Th1 Cells; Th17 Cells | 2020 |
Targeting vascular changes in lesions in multiple sclerosis and experimental autoimmune encephalomyelitis.
Topics: Angiogenesis Inhibitors; Animals; Drug Delivery Systems; Encephalomyelitis, Autoimmune, Experimental; Humans; Indoles; Multiple Sclerosis; Pyrroles; Thalidomide | 2012 |
[Effects of atorvastatin in multiple sclerosis].
Topics: Animals; Anticholesteremic Agents; Atorvastatin; Encephalomyelitis, Autoimmune, Experimental; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Multiple Sclerosis; Pyrroles | 2003 |
18 other study(ies) available for pyrroles and Allergic Encephalomyelitis
Article | Year |
---|---|
Synergistic effects of atorvastatin and all-trans retinoic acid in ameliorating animal model of multiple sclerosis.
Topics: Animals; Atorvastatin; Brain; Cytokines; Disease Models, Animal; Drug Synergism; Encephalomyelitis, Autoimmune, Experimental; Female; Forkhead Transcription Factors; Heptanoic Acids; Mice; Multiple Sclerosis; Pyrroles; T-Lymphocytes, Regulatory; Tretinoin; Weight Loss | 2014 |
Neither T-helper type 2 nor Foxp3+ regulatory T cells are necessary for therapeutic benefit of atorvastatin in treatment of central nervous system autoimmunity.
Topics: Adenylyl Cyclases; Animals; Atorvastatin; Cell Differentiation; Cell Proliferation; Cytokines; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Forkhead Transcription Factors; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-4; Mice; Mice, Inbred C57BL; Mice, Transgenic; Pyrroles; Rats; STAT6 Transcription Factor; T-Lymphocytes, Regulatory; Th2 Cells | 2014 |
Inhibition of Vascular Endothelial Growth Factor Receptor 2 Exacerbates Loss of Lower Motor Neurons and Axons during Experimental Autoimmune Encephalomyelitis.
Topics: Angiogenesis Inhibitors; Animals; Axons; Encephalomyelitis, Autoimmune, Experimental; Female; Indoles; Lumbar Vertebrae; Mice; Mice, Inbred C57BL; Motor Neurons; Pyrroles; Signal Transduction; Spinal Cord; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2016 |
Discovery of a JAK3-Selective Inhibitor: Functional Differentiation of JAK3-Selective Inhibition over pan-JAK or JAK1-Selective Inhibition.
Topics: Animals; Arthritis, Experimental; Disease Models, Animal; Drug Discovery; Encephalomyelitis, Autoimmune, Experimental; Humans; Interleukin-10; Interleukin-1beta; Janus Kinase 1; Janus Kinase 3; Macrophages; Mice; Models, Molecular; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Rats; Th1 Cells; Th17 Cells; Tumor Necrosis Factor-alpha | 2016 |
Tolerogenic Dendritic Cells Generated with Tofacitinib Ameliorate Experimental Autoimmune Encephalomyelitis through Modulation of Th17/Treg Balance.
Topics: Animals; CD4 Lymphocyte Count; Cells, Cultured; Dendritic Cells; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Immune Tolerance; Immunotherapy, Adoptive; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; T-Lymphocytes, Regulatory; Th1 Cells; Th17 Cells | 2016 |
In vivo modification of tRNA with an artificial nucleobase leads to full disease remission in an animal model of multiple sclerosis.
Topics: Animals; Brain; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Genetic Therapy; Mice, Inbred C57BL; Multiple Sclerosis; Pentosyltransferases; Pyrimidinones; Pyrroles; RNA, Transfer; Thioguanine | 2017 |
Antagonizing dopamine D1-like receptor inhibits Th17 cell differentiation: preventive and therapeutic effects on experimental autoimmune encephalomyelitis.
Topics: Adoptive Transfer; Animals; Benzazepines; Cell Differentiation; Cell Polarity; Dendritic Cells; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Humans; Interleukin-17; Lymphocyte Activation; Mice; Pyridines; Pyrroles; Receptors, Dopamine D1; T-Lymphocytes, Helper-Inducer | 2008 |
VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE.
Topics: Angiogenesis Inhibitors; Angiogenic Proteins; Animals; Blood Vessels; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Glycoproteins; Indoles; Laminin; Mice; Mice, Inbred C57BL; Myelin Sheath; Myelin-Oligodendrocyte Glycoprotein; Neovascularization, Pathologic; Peptide Fragments; Pyrroles; RNA, Messenger; Spinal Cord; Up-Regulation; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Wallerian Degeneration | 2009 |
Divergent actions by inhibitors of DP IV and APN family enzymes on CD4+ Teff cell motility and functions.
Topics: Animals; CD13 Antigens; CD4-Positive T-Lymphocytes; Cells, Cultured; Chemokine CXCL12; Chemotaxis; Dipeptidyl Peptidase 4; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Enzyme Inhibitors; Female; Humans; Hydroxamic Acids; Lymphocyte Activation; Lysine; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Pyrroles; Pyrrolidines; Thiazoles; Transgenes | 2011 |
Low dose CP-690,550 (tofacitinib), a pan-JAK inhibitor, accelerates the onset of experimental autoimmune encephalomyelitis by potentiating Th17 differentiation.
Topics: Animals; Cell Differentiation; Encephalomyelitis, Autoimmune, Experimental; HEK293 Cells; Humans; Janus Kinase 3; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Phosphorylation; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Smad2 Protein; STAT1 Transcription Factor; STAT3 Transcription Factor; STAT5 Transcription Factor; Th1 Cells; Th17 Cells; Th2 Cells | 2012 |
Immunomodulatory synergy by combining atorvastatin and rapamycin in the treatment of experimental autoimmune encephalomyelitis (EAE).
Topics: Animals; Atorvastatin; Blotting, Western; Cytokines; Drug Synergism; Drug Therapy, Combination; Encephalomyelitis, Autoimmune, Experimental; Enzyme-Linked Immunosorbent Assay; Extracellular Signal-Regulated MAP Kinases; Female; Flow Cytometry; Heptanoic Acids; Immunologic Factors; Mice; Mice, Inbred C57BL; Pyrroles; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Sirolimus; Spinal Cord; T-Lymphocytes | 2012 |
Tackling multiple sclerosis.
Topics: Animals; Antigen Presentation; Atorvastatin; Central Nervous System Diseases; Encephalomyelitis, Autoimmune, Experimental; Heptanoic Acids; Histocompatibility Antigens Class II; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice; Multiple Sclerosis; Pyrroles; T-Lymphocytes | 2002 |
The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.
Topics: Adoptive Transfer; Amino Acid Sequence; Animals; Antigen-Presenting Cells; Atorvastatin; Cell Division; Central Nervous System Diseases; Cytokines; DNA-Binding Proteins; Encephalomyelitis, Autoimmune, Experimental; Female; Gene Expression; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Macrophages; Mice; Microglia; Molecular Sequence Data; Multiple Sclerosis; Nuclear Proteins; Paralysis; Phosphorylation; Pyrroles; RNA, Messenger; STAT4 Transcription Factor; STAT6 Transcription Factor; Th2 Cells; Trans-Activators | 2002 |
Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin.
Topics: Animals; Apoptosis; Atorvastatin; CD4-Positive T-Lymphocytes; Cell Cycle; Cell Division; Cell Line; Encephalomyelitis, Autoimmune, Experimental; Female; Genes, MHC Class II; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Mice; Mice, Inbred Strains; Myelin Proteolipid Protein; Paralysis; Peptide Fragments; Pyrroles; Recurrence; Spinal Cord; Th1 Cells | 2003 |
Isoprenoids determine Th1/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin.
Topics: Animals; Atorvastatin; Cell Differentiation; Cell Membrane; Cell Proliferation; Cells, Cultured; Cholesterol; Encephalomyelitis, Autoimmune, Experimental; Female; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice; Mice, Inbred Strains; Mice, Transgenic; Protein Prenylation; Pyrroles; ras Proteins; rhoA GTP-Binding Protein; Terpenes; Th1 Cells; Th2 Cells | 2006 |
Immunomodulatory synergy by combination of atorvastatin and glatiramer acetate in treatment of CNS autoimmunity.
Topics: Animals; Atorvastatin; Cells, Cultured; Cytokines; Drug Therapy, Combination; Encephalomyelitis, Autoimmune, Experimental; Female; Glatiramer Acetate; Heptanoic Acids; Immunologic Factors; Mice; Mice, Inbred Strains; Monocytes; Multiple Sclerosis; Peptides; Pyrroles; T-Lymphocytes, Regulatory; Th1 Cells | 2006 |
3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor Atorvastatin mediated effects depend on the activation status of target cells in PLP-EAE.
Topics: Animals; Atorvastatin; Encephalomyelitis, Autoimmune, Experimental; Flow Cytometry; Gene Expression; Heptanoic Acids; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leukocytes; Lymph Nodes; Male; Mice; Multiple Sclerosis; Myelin Proteolipid Protein; Oligonucleotide Array Sequence Analysis; Peptide Fragments; Pyrroles; Spinal Cord | 2006 |
Combined treatment with atorvastatin and minocycline suppresses severity of EAE.
Topics: Animals; Anti-Bacterial Agents; Atorvastatin; Body Weight; Cell Proliferation; Cytokines; Drug Therapy, Combination; Encephalomyelitis, Autoimmune, Experimental; Enzyme-Linked Immunosorbent Assay; Female; Glial Fibrillary Acidic Protein; Glycoproteins; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice; Mice, Inbred C57BL; Minocycline; Multiple Sclerosis; Myelin-Oligodendrocyte Glycoprotein; Neurologic Examination; Peptide Fragments; Pyrroles; Stereotaxic Techniques; T-Lymphocytes; Time Factors | 2008 |